Prosecution Insights
Last updated: April 19, 2026

Create Medicines Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18420382 CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER GAMETT, DANIEL C 1647 Non-Final OA Jan 23, 2024
17837093 THERAPEUTIC CELL COMPOSITIONS AND METHODS OF MANUFACTURING AND USE THEREOF HILL, KEVIN KAI 1638 Final Rejection Jun 10, 2022
17514828 ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF PENNINGTON, KATIE LEIGH 1634 Final Rejection Apr 04, 2022
17209712 ENGINEERED PHAGOCYTIC RECEPTOR COMPOSITIONS AND METHODS OF USE THEREOF KOLKER, DANIEL E 1645 Final Rejection Mar 23, 2021

Managing Create Medicines Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month